Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)

SHE:002370 Revenue

Zhejiang Yatai Pharmaceutical had revenue of 59.58M CNY in the quarter ending March 31, 2026, a decrease of -7.71%. This brings the company's revenue in the last twelve months to 318.16M, down -10.88% year-over-year. In the year 2025, Zhejiang Yatai Pharmaceutical had annual revenue of 323.14M, down -20.25%.

• Revenue (ttm): 318.16M
• Revenue Growth: -10.88%
• P/S Ratio: 15.14
• Revenue / Employee: 601.44K
• Employees: 529
• Market Cap: 4.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	323.14M	-82.04M	-20.25%
Dec 31, 2024	405.17M	-15.47M	-3.68%
Dec 31, 2023	420.64M	47.20M	12.64%
Jan 1, 2023	373.44M	58.31M	18.50%
Jan 1, 2022	315.13M	-199.75M	-38.80%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error